The impact of the Covid-19 pandemic on breast cancer early detection and screening JD Figueroa, E Gray, N Pashayan, S Deandrea, A Karch, DB Vale, ... Preventive medicine 151, 106585, 2021 | 96 | 2021 |
Evaluation of a stratified national breast screening program in the United Kingdom: an early model-based cost-effectiveness analysis E Gray, A Donten, N Karssemeijer, C Van Gils, DG Evans, S Astley, ... Value in Health 20 (8), 1100-1109, 2017 | 65 | 2017 |
Health economic evaluation of a serum-based blood test for brain tumour diagnosis: exploration of two clinical scenarios E Gray, HJ Butler, R Board, PM Brennan, AJ Chalmers, T Dawson, ... BMJ open 8 (5), e017593, 2018 | 55 | 2018 |
Independent validation of the PREDICT breast cancer prognosis prediction tool in 45,789 patients using Scottish Cancer Registry data E Gray, J Marti, DH Brewster, JC Wyatt, PS Hall, ... British journal of cancer 119 (7), 808-814, 2018 | 53 | 2018 |
A meta-analysis comparing the diagnostic performance of abbreviated MRI and a full diagnostic protocol in breast cancer GC Baxter, A Selamoglu, JW Mackay, S Bond, E Gray, FJ Gilbert Clinical Radiology 76 (2), 154. e23-154. e32, 2021 | 50 | 2021 |
Discrete choice experiments of pharmacy services: a systematic review C Vass, E Gray, K Payne International journal of clinical pharmacy 38, 620-630, 2016 | 48 | 2016 |
Content of Health Economics Analysis Plans (HEAPs) for trial-based economic evaluations: expert Delphi consensus survey JC Thorn, CF Davies, ST Brookes, SM Noble, M Dritsaki, E Gray, ... Value in Health 24 (4), 539-547, 2021 | 42 | 2021 |
Survival estimates stratified by the Nottingham Prognostic Index for early breast cancer: a systematic review and meta-analysis of observational studies E Gray, A Donten, K Payne, PS Hall Systematic reviews 7, 1-9, 2018 | 24 | 2018 |
Chemotherapy effectiveness in trial-underrepresented groups with early breast cancer: a retrospective cohort study E Gray, J Marti, JC Wyatt, DH Brewster, PS Hall, ... PLoS medicine 16 (12), e1003006, 2019 | 22 | 2019 |
Clinical validation of a spectroscopic liquid biopsy for earlier detection of brain cancer JM Cameron, PM Brennan, G Antoniou, HJ Butler, L Christie, JJA Conn, ... Neuro-oncology advances 4 (1), vdac024, 2022 | 21 | 2022 |
Health economics education in undergraduate medical degrees: an assessment of curricula content and student knowledge E Gray, PK Lorgelly Medical teacher 32 (5), 392-399, 2010 | 20 | 2010 |
Healthcare use and costs in the last year of life: a national population data linkage study K Diernberger, X Luta, J Bowden, M Fallon, J Droney, E Lemmon, E Gray, ... BMJ Supportive & Palliative Care 14 (e1), e885-e892, 2024 | 18 | 2024 |
How do individuals’ health behaviours respond to an increase in the supply of health care? Evidence from a natural experiment E Fichera, E Gray, M Sutton Social Science & Medicine 159, 170-179, 2016 | 18 | 2016 |
Early economic evaluation to guide the development of a spectroscopic liquid biopsy for the detection of brain cancer E Gray, JM Cameron, HJ Butler, MD Jenkinson, MG Hegarty, DS Palmer, ... International journal of technology assessment in health care 37 (1), e41, 2021 | 15 | 2021 |
Barriers and facilitators to model replication within health economics E McManus, D Turner, E Gray, H Khawar, T Okoli, T Sach Value in Health 22 (9), 1018-1025, 2019 | 13 | 2019 |
Valuing preferences for the process and outcomes of clinical genetics services: a pilot study E Gray, M Eden, C Vass, M McAllister, J Louviere, K Payne The Patient-Patient-Centered Outcomes Research 9, 135-147, 2016 | 12 | 2016 |
Breast Screening Working Group (WG2) of the COVID-19 and Cancer Global Modelling Consortium. The impact of the COVID-19 pandemic on breast cancer early detection and screening JD Figueroa, E Gray, N Pashayan, S Deandrea, A Karch, DB Vale, ... Prev Med 151, 106585, 2021 | 8 | 2021 |
Real-world evidence was feasible for estimating effectiveness of chemotherapy in breast cancer: a cohort study E Gray, J Marti, DH Brewster, JC Wyatt, R Piaget-Rossel, PS Hall Journal of clinical epidemiology 109, 125-132, 2019 | 7 | 2019 |
SATURNE Advisory Group. Independent validation of the PREDICT breast cancer prognosis prediction tool in 45 789 patients using Scottish Cancer Registry data E Gray, J Marti, DH Brewster, JC Wyatt, PS Hall Br J Cancer 119 (7), 808-814, 2018 | 7 | 2018 |
Risk of missing colorectal cancer with a COVID-adapted diagnostic pathway using quantitative faecal immunochemical testing Y Maeda, E Gray, JD Figueroa, PS Hall, D Weller, MG Dunlop, FVN Din BJS open 5 (4), 2021 | 5 | 2021 |